Gayle Deflin, Director at Amphastar Pharmaceuticals, Inc. (AMPH), sold 8,326 shares at $55.45 ($462K) on 2023-11-14, disclosed to the SEC on 2023-11-15.
Open-market sale of $462k AMPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.45 | 4,163 | $231K | 50.0% |
| 2 | $55.45 | 4,163 | $231K | 50.0% |
| Total | $55.45 avg | 8,326 | $462K | 100% |
| Filing → |